Category: Breathing Disorders

Breathing Disorders

Two-Thirds of Households Have a Person Who Snores

Nasal dilator manufacturer Mute recently commissioned a Harris Poll to better understand how common snoring is and the impact it has on others.

EXciteOSA, Daytime Sleep Apnea Therapy Device, Surpasses 50,000 Patient Session Milestone
New Studies: Sleep Apnea Pill Shows Durability of Effect & Improved Quality of Life in Mild to Severe OSA
Continued CPAP Use Linked to 39% Higher Chance of Survival Over 3-Year Period
Sleep Research Society Focus Group on Non-CPAP Alternatives Now Available on YouTube
Sleep Apnea Detection Tool Fuses Expert Knowledge & Deep Learning Features
Sommetrics Launches AerSleep II Pivotal Clinical Study for Sleep Apnea & Raises $11M

Breathing Disorders

Women Actually Snore More Than Men, According to Mintal Sleep Tracker Data

Wellness-focused tech brand Mintal released a sleep habits report that includes insights stemming from its AI-driven Mintal Tracker app.

Breathing Disorders

Can Sleep Apnea Cause Erectile Dysfunction?

Sleep apnea can take a toll on the hormonal balances in the male body, leading to problems including erectile dysfunction.

Obstructive Sleep Apnea

Treating Obstructive Sleep Apnea: AASM Releases Guidance for Follow-Up Sleep Studies

When should a treated OSA patient have a repeat PSG or HSAT? The AASM releases its first statement to guide clinicians.

Central Sleep Apnea

FDA Approves Next-Gen Remedē System for Central Sleep Apnea

The remedē EL-X System features enhanced functionality, simplifies the implant procedure, and provides greater device longevity.

Hypoventilation

CPAP vs NIV for Ambulatory Patients With Obesity Hypoventilation Syndrome

Continuous positive airway pressure (CPAP) may be a preferred alternative to noninvasive ventilation (NIV) as first-line therapy in stable ambulatory patients with obesity hypoventilation syndrome (OHS) and concurrent...

Hypoxia

How Intermittent Hypoxia Impacts Jaw Cartilage Growth

Previous work had primarily focused on how intermittent hypoxia affects only bone growth. Here, a team examined growth of cartilage cells.

Snoring

Signifier Raises $35M to Accelerate Commercialization of eXciteOSA Therapy

Proceeds of the financing will be directed towards commercialization of eXciteOSA in core target markets, continued development of proprietary digital patient and physician interface platforms, the generation of additional clinical data to reinforce the therapeutic efficacy of eXciteOSA, and progressing reimbursement.